Vaccine Reality Dose
Bharat Biotech failed to halt clinical trials after one person developed serious side-effects during the testing of Covaxin, its indigenously developed Covid-19 vaccine candidate. Dr. Srinath Reddy, President of Public Health Foundation of India, and ET’s Teena Thacker take us through the protocols and challenges of developing a vaccine.
